A genetic key to strengthening the power of T lymphocytes found by American scientists could reverse this situation. They design a "super T lymphocyte" that multiplies its potential to attack incurable cancers by a hundred.
This ability strengthens lymphocytes and gives them unique abilities to persist without the help of CD4+ T cells. The team has already begun to test the new strategy in patients. In collaboration with Kole Roybal, co-author of the study, the FDA has announced an investigation into the study.